{"id":32765,"date":"2014-10-04T12:58:44","date_gmt":"2014-10-04T16:58:44","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=32765"},"modified":"2014-10-04T12:58:44","modified_gmt":"2014-10-04T16:58:44","slug":"tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765","title":{"rendered":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/04\/2014 (wallstreetpr) \u2013 Ever since the outbreak of the deadly Ebola virus, a lot of drug companies have joined hands to fight against the deadly virus. <strong>Tekmira Pharmaceutical Corporation (NASDAQ:TKMR), <\/strong>is one of those companies which has garnered interest not only from investors but also from health regulators.<\/p>\n<p style=\"text-align: justify;\">With the recently found first case of the disease in the U.S., there is increasing interest in similar companies that are that are in the process of introducing a successful therapy. Based out of Burnaby, a city in British Columbia, Canada, Tekmira Pharmaceutical Corporation (NASDAQ:TKMR)\u2019s TKM-Ebola therapy has been used on patients which also include, Richard Sacra, an American missionary who has contracted the disease while in Liberia.<\/p>\n<p style=\"text-align: justify;\">The initial tests have helped Tekmira Pharmaceutical Corporation\u2019s (NASDAQ:TKMR) stock price to climb from around $10 i.e. the price before the USFDA to a closing price of $29.53 on 3<sup>rd<\/sup> October, 2014. Meanwhile, the company had revenues of $15.5 million in FY13 and a loss of 87 cents per share, and the financial prospects of the company are not that great but the company will ride the tide till there is Ebola scare.<\/p>\n<p style=\"text-align: justify;\">The first Ebola case was reported in the U.S related to a patient named Thomas E. Duncan, who lives in a Texas apartment and had contracted the disease while in Liberia. After the detection of the first case also known as \u201cPatient Zero\u201d by Dallas city officials, direct contact among people in the area has been very limited. It\u2019s been three days since Mr. Duncan was diagnosed with Ebola.<\/p>\n<p style=\"text-align: justify;\">Though Ebola is not an airborne disease and spreads mainly through direct contact and bodily fluids of the patients, people are wary of even shaking hands with strangers. The fear among people is not only due to misinformation but also as a result of the manner in which the situation has been handled by local officials.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/04\/2014 (wallstreetpr) \u2013 Ever since the outbreak of the deadly Ebola virus, a lot of drug companies have joined hands to fight against [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":18049,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[10112,4911,10110,10109,10113,10111,10114],"stock_ticker":[],"class_list":["post-32765","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-ebola-scare","tag-nasdaqtkmr","tag-tekmira-pharmaceutical-corporation","tag-tekmira-pharmaceutical-corporation-nasdaqtkmr","tag-texas","tag-tkm-ebola","tag-usfda","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/04\/2014 (wallstreetpr) \u2013 Ever since the outbreak of the deadly Ebola virus, a lot of drug companies have joined hands to fight against [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-04T16:58:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"168\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands\",\"datePublished\":\"2014-10-04T16:58:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\"},\"wordCount\":328,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"keywords\":[\"Ebola Scare\",\"NASDAQ:TKMR\",\"Tekmira Pharmaceutical Corporation\",\"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR)\",\"Texas\",\"TKM-Ebola\",\"USFDA\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\",\"name\":\"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"datePublished\":\"2014-10-04T16:58:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"width\":300,\"height\":168},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765","og_locale":"en_US","og_type":"article","og_title":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR","og_description":"Boston, MA 10\/04\/2014 (wallstreetpr) \u2013 Ever since the outbreak of the deadly Ebola virus, a lot of drug companies have joined hands to fight against [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-04T16:58:44+00:00","og_image":[{"width":300,"height":168,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands","datePublished":"2014-10-04T16:58:44+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765"},"wordCount":328,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","keywords":["Ebola Scare","NASDAQ:TKMR","Tekmira Pharmaceutical Corporation","Tekmira Pharmaceutical Corporation (NASDAQ:TKMR)","Texas","TKM-Ebola","USFDA"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765","url":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765","name":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","datePublished":"2014-10-04T16:58:44+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","width":300,"height":168},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tekmira-pharmaceutical-corporation-nasdaqtkmr-grabbed-opportunity-with-both-hands-32765#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Tekmira Pharmaceutical Corporation (NASDAQ:TKMR) Grabbed Opportunity With Both Hands"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/32765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=32765"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/32765\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/18049"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=32765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=32765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=32765"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=32765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}